New Sleep Apnea Treatment: Ultrasound-Guided Nerve Stimulation Shows Promise

A new, less invasive treatment for obstructive sleep apnea is demonstrating a 93% success rate in early trials, offering a potential alternative to the widely used but often poorly tolerated CPAP machine. Researchers at Flinders University in Australia have developed a technique involving the stimulation of the hypoglossal nerve, which controls the muscles of the tongue.

Obstructive sleep apnea affects nearly one billion people worldwide, a condition characterized by repeated interruptions in breathing during sleep. These interruptions can lead to serious cardiovascular and cognitive health problems. The current gold standard treatment, Continuous Positive Airway Pressure (CPAP) therapy, requires patients to wear a mask throughout the night, delivering a constant stream of air to keep airways open. However, approximately 50% of patients find CPAP masks uncomfortable and discontinue use over the long term.

The Flinders University team’s approach avoids the require for a mask or major surgery. Instead, small electrodes are positioned under the skin, guided by ultrasound, without the need for general anesthesia. The hypoglossal nerve, when stimulated, prevents the tongue from relaxing and obstructing the airway during sleep. Initial clinical studies, involving 14 participants with moderate to severe sleep apnea, showed a significant improvement in airflow for 93% of those treated. The study also indicated a substantial decrease in critical airway pressure, comparable to the effects achieved with CPAP therapy.

“What we have is a significant step forward in treating sleep apnea,” said Amal M. Osman, who led the research team, according to reporting from passeportsante.net. “The non-invasive nature of the procedure and the high success rate offer a promising option for patients who struggle with CPAP.”

The benefits extend beyond patient comfort. The procedure’s minimal invasiveness reduces surgical risks and associated medical costs. The system’s adaptability allows for individualized adjustments to stimulation parameters, catering to each patient’s specific needs. Participants in the trial reported a high level of acceptance and experienced no major complications.

Unlike CPAP, which requires continuous use throughout the night, this new method doesn’t impose a constant constraint. Researchers suggest it could even serve as a “test” to identify patients who would benefit most from a permanent implant, or be used in conjunction with other therapies for a personalized treatment plan. However, larger-scale studies are needed to confirm the long-term durability of the benefits.

Further research is currently underway to assess the long-term effects and optimal application of this nerve stimulation technique. The Flinders University team is continuing to refine the procedure and explore its potential to improve the quality of life for individuals suffering from obstructive sleep apnea.